These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 17534687

  • 21. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [Abstract] [Full Text] [Related]

  • 22. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE, Koniaris LG, Snell SE, Spector S, Powell J, Avisar E, Moffat F, Livingstone AS, Franceschi D.
    Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
    Katz A, Gage I, Evans S, Shaffer M, Fleury T, Smith FP, Flax R, Drogula C, Petrucci P, Magnant C.
    Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
    Tan JC, McCready DR, Easson AM, Leong WL.
    Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
    [Abstract] [Full Text] [Related]

  • 27. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    EORTC Breast Cancer Cooperative GroupDepartment of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands. n.bijker@nki.nl, EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.
    J Clin Oncol; 2006 Jul 20; 24(21):3381-7. PubMed ID: 16801628
    [Abstract] [Full Text] [Related]

  • 28. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K.
    Med Sci Monit; 2005 Mar 20; 11(3):RA86-93. PubMed ID: 15735580
    [Abstract] [Full Text] [Related]

  • 29. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R, Dhage S, Guth A, Shapiro RL, Axelrod DM, Roses DF, Formenti SC.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):e159-64. PubMed ID: 22579378
    [Abstract] [Full Text] [Related]

  • 30. An argument against routine sentinel node mapping for DCIS.
    Farkas EA, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM.
    Am Surg; 2004 Jan 01; 70(1):13-7; discussion 17-8. PubMed ID: 14964539
    [Abstract] [Full Text] [Related]

  • 31. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
    Porembka MR, Abraham RL, Sefko JA, Deshpande AD, Jeffe DB, Margenthaler JA.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2709-19. PubMed ID: 18483831
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R, Antoine M, Barranger E, Dubernard G, Salem C, Daraï E, Uzan S.
    Breast J; 2008 Oct 01; 14(1):55-60. PubMed ID: 18186866
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF.
    Cancer; 2003 Nov 15; 98(10):2105-13. PubMed ID: 14601079
    [Abstract] [Full Text] [Related]

  • 38. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P, Schrenk P, Reitsamer R, Koeberle-Wuehrer R, Tausch C, Roka S, Riedl O, Poestlberger S, Hecke D, Janauer M, Haid A.
    Breast; 2007 Oct 15; 16(5):520-6. PubMed ID: 17566737
    [Abstract] [Full Text] [Related]

  • 39. Ductal carcinoma in situ of the breast: our experience.
    Ruggiero R, Procaccini E, Sanguinetti A, Cremone C, Gili S, Docimo G, Docimo L, Sparavigna L, Gubitosi A, Parmeggiani D, Avenia N.
    G Chir; 2009 Mar 15; 30(3):121-4. PubMed ID: 19351465
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.